The National Reconstruction Fund Corporation has invested $150 million in life sciences venture capital firm Brandon Capital, in a major push to keep Australia’s medical breakthroughs from heading offshore at the point of commercialisation. The investment — the NRF’s second largest to date — is aimed at strengthening Australia’s sovereign medical manufacturing capability by supporting…

The post NRF injects $150m into Brandon Capital life sciences fund appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.